Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC
Conditions
- Non Small Cell Lung Cancer
Interventions
- BIOLOGICAL: chemotherapy followed dendritic cells
- DRUG: pemetrexed and carboplatin
Sponsor
Shanghai Chest Hospital
Collaborators